NCT04676685View on ClinicalTrials.gov

A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 16, 2020

Primary Completion Date

June 23, 2021

Study Completion Date

June 23, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

E2730

E2730 capsules.

DRUG

E2730-matched placebo

E2730-matched placebo capsules.

Trial Locations (1)

90806

Collaborative Neuroscience Research, LLC., Long Beach

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT04676685 - A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants | Biotech Hunter | Biotech Hunter